ABCA1 and colorectal cancer: High ABCA1 expression promotes a poor immune microenvironment and low survival in patients with gastric adenocarcinoma 28, and APOA1 serves as a novel therapeutic option to inhibit colorectal cancer-promoting metastasis by modulating intracellular cholesterol metabolism 29.